Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells

Stereoselective excretion and first-pass metabolism of clausenamide enantiomers

(2013) Chuan-jiang Zhu et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Determination of the enantioselectivity of six chiral aryloxy aminopropanol drugs transport across Caco-2 cell monolayers

(2012) Ye Tian et al.   Acta Pharmaceutica Sinica B

Inhibitory Effects of Furanocoumarin Derivatives in Kampo Extract Medicines on P-Glycoprotein at the Blood–Brain Barrier

(2011) Kazunori Iwanaga et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine

(2011) Corbin J. Bachmeier et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action

(2010) Yi Zhang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib

(2009) Y. Chen et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Role of P-Glycoprotein in Intestinal Transport versus the BBB Transport of Tetraphenylphosphonium

(2009) Avi Swed et al.   MOLECULAR PHARMACEUTICS

Stereoselective plasma protein binding and target tissue distribution of clausenamide enantiomers in rats

(2008) Chuan Jiang Zhu et al.   CHIRALITY